Deletion of a small consensus region at 6q15, including the MAP3K7 gene, is significantly associated with high-grade prostate cancers

Clinical Cancer Research

Volumn 13, Issue 17, 2007, Pages 5028-5033

  Liu, Wennuan ^a   Chang, Bao Li ^a   Cramer, Scott ^a   Koty, Patrick P ^a   Li, Tao ^a   Sun, Jishan ^a   Turner, Aubrey R ^a   Kap Herr, Chrisvon ^a   Bobby, Peggy ^a   Rao, Jianyu ^b   Zheng, S Lilly ^a   Isaacs, William B ^c   Xu, Jianfeng ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 7; MAP KINASE KINASE KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER GRADING; CHROMOSOME; CONTROLLED STUDY; DNA DETERMINATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE LOCATION; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM; CHROMOSOME 6; CHROMOSOME DELETION; GENETICS; MALE; PATHOLOGY; PROSTATE TUMOR;

CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 6; GENE DELETION; HUMANS; MALE; MAP KINASE KINASE KINASES; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS;

EID: 34548832771     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-0300     Document Type: Article

References (13)

1. Dong JT. Chromosomal deletions and tumor suppressor genes in prostate cancer. Cancer Metastasis Rev 2001;20:173-93.
2. Sun J, Liu W, Adams TA, et al. DNA copy number alterations in prostate cancers: a combined analysis of published CGH studies. Prostate 2007;67:692-700.
3. Lucito R, Healy J, Alexander J, et al. Representational oligonucleotide microarray analysis: a high-resolution method to detect genome copy number variation. Genome Res 2003;13:2291-305.
4. Liu W, Chang B, Sauvageot J, et al. Comprehensive assessment of DNA copy number alterations in human prostate cancers using Affymetrix 100K SNP mapping array. Genes Chromosomes Cancer 2006;45:1018-32.
5. Bova GS, MacGrogan D, Levy A, Pin SS, Bookstein R, Isaacs WB. Physical mapping of chromosome 8p22 markers and their homozygous deletion in a metastatic prostate cancer. Genomics 1996;35:46-54.
6. Nannya Y, Sanada M, Nakazaki K, et al. A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. Cancer Res 2005;65:6071-9.
7. Lin M, Wei LJ, Sellers WR, Lieberfarb M, Wong WH, Li C. dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data. Bioinformatics 2004;20:1233-40.
8. Cooney KA, Wetzel JC, Consolino CM, Wojno KJ. Identification and characterization of proximal 6q deletions in prostate cancer. Cancer Res 1996;56:4150-3.
9. Srikantan V, Sesterhenn IA, Davis L, et al. Allelic loss on chromosome 6Q in primary prostate cancer. Int J Cancer 1999;84:331-5.
10. Hyytinen ER, Saadut R, Chen C, et al. Defining the region(s) of deletion at 6q16-q22 in human prostate cancer. Genes Chromosomes Cancer 2002;34:306-12.
11. Konishi N, Nakamura M, Kishi M, et al. Genetic mapping of allelic loss on chromosome 6q within heterogeneous prostate carcinoma. Cancer Sci 2003;94:764-8.
12. Yamaguchi K, Shirakabe K, Shibuya H, et al. Identification of a member of the MAPKKK family as a potential mediator of TGF-β signal transduction. Science 1995;270:2008-11.
13. Bierie B, Moses HL. TGF-β and cancer. Cytokine Growth Factor Rev 2006;17:29-40.